Two large independent* economic studies demonstrated: 3M™ V.A.C.® Therapy delivers lower total cost to treat1,2
The newest health economic analysis2 of real-world health insurance claims data provided insights into the cost-effectiveness of negative pressure wound therapy (NPWT). The analysis showed patients who received V.A.C.® Therapy had lower total and wound-related treatment costs than patients who received competitor NPWT in all wound types across all time periods studied.
Methodology2
Retrospective analysis of U.S. insurance claims database compared total and wound-related costs for patients who received V.A.C.® Therapy versus competitor NPWT in the outpatient setting between January 2016 and September 2018. Costs were compared across care settings and wound types at 30 days, 3 months, and 12 months after initial claim.
Interested in downloading this study? Visit our website for more information.
1. Law A, Cyhaniuk A, Krebs B. Comparison of health care costs and hospital readmission rates associated with negative pressure wound therapies. Wounds. 2015 Mar;27(3):63-72. PMID: 25786078.
2. Law A L. Krebs B. Karnik B. Griffin L. Comparison of Healthcare Costs Associated With Patients Receiving Traditional Negative Pressure Wound Therapies in the Post Acute Setting. Cureus 12(11):e11790. DOI 10.7759/cureus.11790.
NOTE: Specific indications, contraindications, warnings, precautions, and safety information exist for these products and therapies. Please consult a clinician and product instructions for use prior to application. Rx only.
© 2021 3M. All rights reserved. 3M and the other marks shown are marks and/or registered marks. Unauthorized use prohibited. All other marks are property of their respective owners. PRA-PM-US-03231 (06/21)